Surgical Science Sweden AB
STO:SUS
Surgical Science Sweden AB?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
111.1
189.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Surgical Science Sweden AB hold over its rivals?
What risks and challenges
does Surgical Science Sweden AB face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Surgical Science Sweden AB.
Provide an overview of the primary business activities
of Surgical Science Sweden AB.
What unique competitive advantages
does Surgical Science Sweden AB hold over its rivals?
What risks and challenges
does Surgical Science Sweden AB face in the near future?
Has there been any significant insider trading activity
in Surgical Science Sweden AB recently?
Summarize the latest earnings call
of Surgical Science Sweden AB.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Surgical Science Sweden AB.
Provide P/S
for Surgical Science Sweden AB.
Provide P/E
for Surgical Science Sweden AB.
Provide P/OCF
for Surgical Science Sweden AB.
Provide P/FCFE
for Surgical Science Sweden AB.
Provide P/B
for Surgical Science Sweden AB.
Provide EV/S
for Surgical Science Sweden AB.
Provide EV/GP
for Surgical Science Sweden AB.
Provide EV/EBITDA
for Surgical Science Sweden AB.
Provide EV/EBIT
for Surgical Science Sweden AB.
Provide EV/OCF
for Surgical Science Sweden AB.
Provide EV/FCFF
for Surgical Science Sweden AB.
Provide EV/IC
for Surgical Science Sweden AB.
Show me price targets
for Surgical Science Sweden AB made by professional analysts.
What are the Revenue projections
for Surgical Science Sweden AB?
How accurate were the past Revenue estimates
for Surgical Science Sweden AB?
What are the Net Income projections
for Surgical Science Sweden AB?
How accurate were the past Net Income estimates
for Surgical Science Sweden AB?
What are the EPS projections
for Surgical Science Sweden AB?
How accurate were the past EPS estimates
for Surgical Science Sweden AB?
What are the EBIT projections
for Surgical Science Sweden AB?
How accurate were the past EBIT estimates
for Surgical Science Sweden AB?
Compare the revenue forecasts
for Surgical Science Sweden AB with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Surgical Science Sweden AB and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Surgical Science Sweden AB against its competitors.
Analyze the profit margins
(gross, operating, and net) of Surgical Science Sweden AB compared to its peers.
Compare the P/E ratios
of Surgical Science Sweden AB against its peers.
Discuss the investment returns and shareholder value creation
comparing Surgical Science Sweden AB with its peers.
Analyze the financial leverage
of Surgical Science Sweden AB compared to its main competitors.
Show all profitability ratios
for Surgical Science Sweden AB.
Provide ROE
for Surgical Science Sweden AB.
Provide ROA
for Surgical Science Sweden AB.
Provide ROIC
for Surgical Science Sweden AB.
Provide ROCE
for Surgical Science Sweden AB.
Provide Gross Margin
for Surgical Science Sweden AB.
Provide Operating Margin
for Surgical Science Sweden AB.
Provide Net Margin
for Surgical Science Sweden AB.
Provide FCF Margin
for Surgical Science Sweden AB.
Show all solvency ratios
for Surgical Science Sweden AB.
Provide D/E Ratio
for Surgical Science Sweden AB.
Provide D/A Ratio
for Surgical Science Sweden AB.
Provide Interest Coverage Ratio
for Surgical Science Sweden AB.
Provide Altman Z-Score Ratio
for Surgical Science Sweden AB.
Provide Quick Ratio
for Surgical Science Sweden AB.
Provide Current Ratio
for Surgical Science Sweden AB.
Provide Cash Ratio
for Surgical Science Sweden AB.
What is the historical Revenue growth
over the last 5 years for Surgical Science Sweden AB?
What is the historical Net Income growth
over the last 5 years for Surgical Science Sweden AB?
What is the current Free Cash Flow
of Surgical Science Sweden AB?
Discuss the annual earnings per share (EPS)
trend over the past five years for Surgical Science Sweden AB.
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
SE |
S
|
Surgical Science Sweden AB
STO:SUS
|
6.2B SEK | 37.8 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
219.7B USD | 32.1 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.8B USD | 71.1 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
138B USD | 48.2 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
133.6B USD | 28 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
106.4B USD | 18.9 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
58.5B USD | 25.8 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
48.7B EUR | 20.5 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
40.8B USD | 25.3 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
260.6B CNY | 18.2 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
31.9B USD | 28.5 |
|
EBIT Growth | EV/EBIT to Growth | |||||
---|---|---|---|---|---|---|
SE |
S
|
Surgical Science Sweden AB
STO:SUS
|
Average EV/EBIT:
32.2
37.8
|
51%
|
0.7 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
32.1
|
22%
|
1.5 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
71.1
|
27%
|
2.6 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
48.2
|
30%
|
1.6 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
28
|
15%
|
1.9 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
18.9
|
17%
|
1.1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
25.8
|
30%
|
0.9 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
20.5
|
21%
|
1 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
25.3
|
12%
|
2.1 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
18.2
|
14%
|
1.3 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
28.5
|
12%
|
2.4 |
|
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.